233 related articles for article (PubMed ID: 19603000)
21. Adenovirus vectors targeting distinct cell types in the retina.
Sweigard JH; Cashman SM; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2219-28. PubMed ID: 19892875
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness of the oncolytic activity induced by Ad5/F35 adenoviral vector is dependent on the cumulative cellular conditions of survival and autophagy.
Kim SY; Kang S; Song JJ; Kim JH
Int J Oncol; 2013 Apr; 42(4):1337-48. PubMed ID: 23403990
[TBL] [Abstract][Full Text] [Related]
23. Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.
Krutzke L; Prill JM; Engler T; Schmidt CQ; Xu Z; Byrnes AP; Simmet T; Kreppel F
J Control Release; 2016 Aug; 235():379-392. PubMed ID: 27302248
[TBL] [Abstract][Full Text] [Related]
24. A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.
Yang M; Yang CS; Guo W; Tang J; Huang Q; Feng S; Jiang A; Xu X; Jiang G; Liu YQ
Cancer Biol Ther; 2017 Nov; 18(11):833-840. PubMed ID: 29144842
[TBL] [Abstract][Full Text] [Related]
25. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.
Sakurai F; Mizuguchi H; Hayakawa T
Gene Ther; 2003 Jun; 10(12):1041-8. PubMed ID: 12776162
[TBL] [Abstract][Full Text] [Related]
26. Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells.
Murakami S; Sakurai F; Kawabata K; Okada N; Fujita T; Yamamoto A; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Nov; 14(21):1525-33. PubMed ID: 17805302
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates.
Sakurai F; Nakamura SI; Akitomo K; Shibata H; Terao K; Kawabata K; Hayakawa T; Mizuguchi H
Gene Ther; 2009 Feb; 16(2):297-302. PubMed ID: 18800152
[TBL] [Abstract][Full Text] [Related]
28. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.
Shayakhmetov DM; Papayannopoulou T; Stamatoyannopoulos G; Lieber A
J Virol; 2000 Mar; 74(6):2567-83. PubMed ID: 10684271
[TBL] [Abstract][Full Text] [Related]
29. Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.
Khare R; May SM; Vetrini F; Weaver EA; Palmer D; Rosewell A; Grove N; Ng P; Barry MA
Mol Ther; 2011 Jul; 19(7):1254-62. PubMed ID: 21505422
[TBL] [Abstract][Full Text] [Related]
30. Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses.
Bradshaw AC; Coughlan L; Miller AM; Alba R; van Rooijen N; Nicklin SA; Baker AH
J Control Release; 2012 Dec; 164(3):394-402. PubMed ID: 22626939
[TBL] [Abstract][Full Text] [Related]
31. Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates.
Sakurai F; Nakamura S; Akitomo K; Shibata H; Terao K; Kawabata K; Hayakawa T; Mizuguchi H
Mol Ther; 2008 Apr; 16(4):726-33. PubMed ID: 18362928
[TBL] [Abstract][Full Text] [Related]
32. Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer.
Parker AL; Waddington SN; Buckley SM; Custers J; Havenga MJ; van Rooijen N; Goudsmit J; McVey JH; Nicklin SA; Baker AH
J Virol; 2009 Jan; 83(1):479-83. PubMed ID: 18945780
[TBL] [Abstract][Full Text] [Related]
33. Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells.
Iguchi K; Sakurai F; Tomita K; Katayama K; Yamaguchi T; Kawabata K; Tagawa M; Kawabata M; Shirakawa T; Mizuguchi H
Cancer Gene Ther; 2012 Feb; 19(2):118-25. PubMed ID: 22076042
[TBL] [Abstract][Full Text] [Related]
34. Coagulation factor binding orientation and dimerization may influence infectivity of adenovirus-coagulation factor complexes.
Irons EE; Flatt JW; Doronin K; Fox TL; Acchione M; Stewart PL; Shayakhmetov DM
J Virol; 2013 Sep; 87(17):9610-9. PubMed ID: 23804638
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes.
Mizuguchi H; Hayakawa T
Gene; 2002 Feb; 285(1-2):69-77. PubMed ID: 12039033
[TBL] [Abstract][Full Text] [Related]
36. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.
Zaiss AK; Foley EM; Lawrence R; Schneider LS; Hoveida H; Secrest P; Catapang AB; Yamaguchi Y; Alemany R; Shayakhmetov DM; Esko JD; Herschman HR
J Virol; 2016 Jan; 90(1):412-20. PubMed ID: 26491162
[TBL] [Abstract][Full Text] [Related]
38. Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer.
Sumarheni S; Hong SS; Josserand V; Coll JL; Boulanger P; Schoehn G; Fender P
Hum Gene Ther; 2014 Apr; 25(4):339-49. PubMed ID: 24512117
[TBL] [Abstract][Full Text] [Related]
39. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction
Lopez-Gordo E; Doszpoly A; Duffy MR; Coughlan L; Bradshaw AC; White KM; Denby L; Nicklin SA; Baker AH
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381574
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of human CD46 by adenovirus serotype 35 vectors.
Sakurai F; Akitomo K; Kawabata K; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Jun; 14(11):912-9. PubMed ID: 17377598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
